Product
AZD8205
1 clinical trial
4 indications
Indication
Breast CancerIndication
CholangiocarcinomaIndication
Ovarian CancerIndication
Endometrial CancerClinical trial
A Phase I/IIa Multi-center, Open-label Master Protocol to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Antitumor Activity of AZD8205 in Participants With Advanced or Metastatic Solid MalignanciesStatus: Recruiting, Estimated PCD: 2025-06-30